Among various factors involved in inducing tumor resistance or anti-apoptotic responses to standard therapies against cancers, sry-related high-mobility box -2 (SOX-2) gene has emerged as an important oncogene which affects tumor cell behavior including proliferation, apoptosis and resistance to standard therapies [44–47]. This evidence concerns the gene SOX2 and neoplasm.